Biotech industry marks big year in South Dakota
From research breakthroughs to major investments and newcomers to the industry to next steps for existing companies, the bioscience industry has much to celebrate in 2018.
From research breakthroughs to major investments and newcomers to the industry to next steps for existing companies, the bioscience industry has much to celebrate in 2018.
SAB Biotherapeutics has raised $22 million in its Series A-2 round, which closed Dec. 15.
It’s one sign of how driving is going to be changing: Behind these tailgating trucks is a high-tech system positioning all of us for the future of transportation.
Sanford Research has hit a key milestone in its efforts to gain FDA approval for ground-breaking use of stem cells in orthopedics and is already pursuing new trials to broaden its efforts.
Think South Dakota is a hard place for startups to find funding? Falls Angel Fund’s recent investments suggest otherwise.
South Dakota Equity Partners has its first investment: A homegrown biotech company with big promise.
Talk about an entrepreneurial dream team. No surprise the chance to hear these business owners sold out, but we have a way you can still learn from their success.
Meet one of the vendors at the 605 Made Holiday Market who is running her bath and body business while studying at SDSU.
“Simply put, this is absolutely fantastic for our biotech future.” The potential for growing bioscience work in the Sioux Falls region is stronger thanks to one new industry entrepreneur.
Is 2019 your year to become a business owner? If you’re thinking about entrepreneurship but have more questions than answers, SiouxFalls.Business has a way to help.